Epitalon (Epithalon)

Product Overview

Epithalon (also Epitalon, Epithalone) is a synthetic tetrapeptide (Ala–Glu–Asp–Gly, AEDG) originally developed in Russia as a model compound for aging and neuroendocrine research. It is the best-characterized synthetic analog of the pineal gland extract Epithalamin.

Epithalon is widely used in research focused on:

• Telomerase and telomere dynamics
• Melatonin secretion and circadian rhythm regulation
• Epigenetic modulation and chromatin structure
• Tumor biology, immune aging, and microvascular changes

Evidence is drawn primarily from in vitro assays, rodent models, and limited human studies performed in specialized gerontological centers. No medical use is approved.

Structure & Identity

• Sequence: Ala–Glu–Asp–Gly (AEDG)
• Type: Synthetic tetrapeptide
• Molecular Formula: C₁₄H₂₂N₄O₉
• Molecular Weight: ~390.35 g/mol
• Related to: Pineal extract Epithalamin

Telomerase and Cellular Lifespan Research

Cellular aging is closely linked to telomere shortening during successive cell divisions:

• Telomeres protect chromosome ends; once critically short, cells enter senescence.
• The telomerase enzyme counteracts this erosion by extending telomeric DNA.

Experimental work with Epithalon has shown:

• Increased telomerase expression and activity in select human cell cultures
• Delayed onset of cellular senescence and extended proliferative capacity in vitro

These effects make Epithalon a useful tool for:

• Probing telomere biology
• Investigating mechanisms that limit or extend cellular lifespan

The broader impact of long-term telomerase modulation in vivo remains an open research question.

Gene Expression, Chromatin, and DNA-Level Effects

Studies—especially from Russian gerontology groups—suggest that Epithalon can influence chromatin organization and gene expression in aging cells:

• Reactivation of genes that were silenced with age
• Modulation of genes involved in:
• Development and differentiation
• Immune system competence
• Cell maintenance and stress resistance

In older human subjects (approximately 60–74 years):

• Courses of pineal peptide complexes (including or analogous to Epithalon) administered for 2–3 years reportedly produced benefits that persisted up to 3 years after treatment.
• Authors propose relatively stable epigenetic and chromatin-level alterations as a possible mechanism.

These findings are intriguing but remain insufficiently replicated outside the originating research centers.

Signaling Pathways & Mechanistic Notes

Across various models, Epithalon has been linked to:

• Telomerase activation – extending replicative potential in vitro
• MAPK/ERK signaling – potentially affecting proliferation, repair, and inflammatory responses
• Circadian-associated transcription factors – consistent with observed normalization of melatonin rhythms

Often-cited labels such as CER, ER2, Twist1, or ZCREB1 are best regarded as proposed or context-specific targets, rather than fully validated, universal mechanisms.

Tumor Growth and Immune Aging (Preclinical)

In oncology and gerontology research, Epithalon and related pineal peptides have been tested in aged rodent models:

• Long-term administration of pineal peptide preparations containing Epithalon has been associated with:
• Reduced spontaneous tumor incidence (including pineal and colon tumors)
• Reported 2.6–2.8× reductions in some tumor types
• Approximately 40% lower overall tumor frequency in certain protocols

Complementary findings include:

• Shifts in gene expression profiles toward patterns interpreted as tumor-suppressive
• Reported improvements in immune parameters and survival metrics in some human cohorts receiving periodic peptide courses

These data are:

• Mostly from a single research tradition
• Not yet supported by large, randomized, multi-center clinical trials
• Complicated by the dual role of telomerase in both cellular maintenance and potential tumor support

Epithalon should therefore be treated strictly as a research reagent, not as an anticancer or immune therapy.

Melatonin, Circadian Rhythm, and Longevity Models

With age, the pineal gland shows reduced function and melatonin output declines. Disordered circadian rhythms are linked to:

• Metabolic dysregulation
• Impaired immune function
• Increased risk of certain malignancies

In rodent studies using:

• Pineal extracts containing Epithalon (e.g., PESI)
• Synthetic Epithalon

researchers have reported:

• Restoration of melatonin secretion after age-related decline
• Improved circadian rhythm stability
• Extended lifespan in specific experimental settings

These results support the use of Epithalon as:

• A tool for exploring neuroendocrine aging
• A probe for the relationship between circadian integrity and longevity

Ocular and Microvascular Aging

Age-related visual decline frequently involves:

• Reduced retinal and choroidal blood flow
• Microvascular degeneration and tissue remodeling

Animal experiments with Epithalon and pineal peptides have shown:

• Enhanced retinal microcirculation in older animals
• Partial reversal of an estimated ~40% age-related reduction in ocular blood flow

These changes may:

• Improve nutrient and oxygen delivery to retinal cells
• Support more efficient metabolic waste clearance

Such findings position Epithalon as a useful compound for studying microvascular and ocular aging, not as a clinical treatment.

Research Background: Prof. Vladlen Khavinson

Much of the Epithalon literature originates from the work of Prof. Vladlen Khavinson, a leading researcher in peptide bioregulation:

• President, European Region of the International Association of Gerontology and Geriatrics (IAGG)
• Director, Saint Petersburg Institute of Bioregulation and Gerontology (Russia)
• Principal author/co-author on numerous studies of:
• Short peptide regulation of genome function
• Peptide applications in gerontology and oncology
• Early clinical translation of peptide interventions

While influential, this research base awaits broader independent confirmation and integration into international regulatory and clinical frameworks.

Article Author

This product description and literature summary were researched, revised, and organized by Dr. Logan, M.D.

• M.D. – Case Western Reserve University School of Medicine
• Additional certification in molecular biology

Selected References

1. Khavinson VK, Anisimov VN, Zabezhinskii MI, et al. Effect of the pineal peptide preparation epithalamin on the life span and pineal and serum melatonin level in old rats. Ann N Y Acad Sci. 1994;719:393–407.
2. Khavinson VK, Chalisova GM, Ashapkin N, Shataeva N, Cartwright A. Mechanisms underlying the immunomodulatory actions of pineal peptides and their use in cancer control strategy. Biol Today. 2012;8:13–20.
3. Khavinson VK, Morozov VG, Abisheva IA, Semenchenko SI, Vanyushin SV. Effect of pineal peptide preparation epithalamin on the proliferation and the development of spontaneous tumors in old rodents. Front Aging Neurosci. 2013;5:128.
4. Khavinson VK, Malinin AV. Gerontological aspects of genome peptide regulation: the role of short peptides. Biogerontology. 2005;6(3):191–201.
5. Khavinson VK, Aliakina IV, Ryzhak GA, Muradian N, Anisimov V, Suchkov RA. Effect of epithalamin on the life span and hypothalamus resistance to aging. Adv Gerontol. 2005;8(2):109–114.
6. Dave S, Kavanagh R, Sheridan J, et al. The association between body mass index and tumor size in soft tissue sarcomas and GIST-soft tumors. Medicine (Baltimore). 2016;95(34):e4578.
7. Khavinson VK, Shataeva LK, Chalisova KA. Effect of regulatory peptides on DNA synthesis in irradiated and non-irradiated splenocytes. Bull Exp Biol Med. 1995;119(1):79–81.
8. Kubanova DV, et al. Deconvolution effect of the pineal-gland peptide on the fatty acid cholesterol esters in the choroidal and ciliary body in albino rats and their correlation with degenerative processes. Tsitologiia. 2008;50(9):779–782.
9. Khavinson V, Goncharova B, Lapin N. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescence accelerated OXYS rats. Neuroendocrinol Lett. 2001;22(4):251–254.
10. Chalisova NI, Litivina ME, Shchukin MM, Drozdov AG, Ryzhak GA, Khavinson VK. Effect of peptide epitalon on microvascular reactions and their role in age-dependent reorganization of tissues. Bull Exp Biol Med. 2006;141(4):452–455.
11. Linke NV, Pankova AA. Peptide regulation of skin fibroblast functions during aging in vitro. Bull Exp Biol Med. 2009;148(1):151–155.
12. Vinogradova IV, Ruslova VV, Zabezhinskii MV, et al. The geroprotective property of epithalon and metformin during aging. Adv Gerontol. 2017;30(1):93–104.